TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …
TORONTO, Aug. 22, 2019 /CNW/ – ACTO was named the winner of a Gold Stevie® Award in the Cloud Platform category in The 16th Annual International Business Awards®. The International Business Awards are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small – are eligible to submit nominations. The 2019 IBAs received …
TORONTO, Jan. 31, 2019 /CNW/ – ACTO Technologies Inc. emerged as a leader in life sciences commercialization by closing a strong calendar year 2018 with 184% revenue growth and a doubled customer base. This past year, ACTO secured global, innovative pharmaceutical, medical device, and dental companies like Kala Pharmaceuticals, Teleflex, and Kulzer Dental US as clients. “At ACTO, we are on a …